Direct effects of ponatinib on vascular endothelial cells: a potential explanation for development of vascular adverse events in CML patients

20 April 2018 (00:00 - 00:00)

Organised by:

About the speaker

Doctor Emir Hadzijusufovic

Ludwig Boltzmann Cluster Oncology, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail

IkB kinase 2 in atherosclerosis

Doctor M. Mussbacher (Vienna, AT)

Presentation thumbnail

Targeted theranostic microbubbles for the delivery of MicroRNA-126: diagnosis and localised treatment/prevention of abdominal aortic aneurysm

Professor K. Peter (Melbourne, AU)

Presentation thumbnail

Electrically silent and stimulable iPSC-derived cardiomyocytes using RNA-guided epigenome editing

Professor J. Hulot (Paris, FR)

Presentation thumbnail

A three-step approach to identify shear stress-sensitive endothelial microRNAs for the optimization of vasculoprotective exercise regimes

Professor B. Schmitz (Ennepetal, DE)

Presentation thumbnail

Potentiated beta-adrenergic effect on calcium handling in autophagy-defective mouse cardiomyocytes

Associate Professor S. Sedej (Graz, AT)

Access the full session

Session thumbnail

Late Breaking Trial session

The Event

Frontiers in CardioVascular Biology 2018

20 April - 22 April 2018

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources